Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An update from Consun Pharmaceutical Group Ltd. ( (HK:1681) ) is now available.
Consun Pharmaceutical Group Ltd. announced significant changes in its board composition and management, effective from February 24, 2025. Ms. Chen Yujun has resigned as an independent non-executive Director to take on the role of Chief Financial Officer, while Mr. Li Zhuoguang is appointed as an independent non-executive Director and the chairman of the Audit Committee. These changes reflect a strategic reallocation of responsibilities aimed at strengthening the company’s governance and financial oversight.
More about Consun Pharmaceutical Group Ltd.
Consun Pharmaceutical Group Limited is a company incorporated in the Cayman Islands, focusing on the pharmaceutical industry. It operates together with its subsidiaries, supplying pharmaceutical products and services.
YTD Price Performance: -15.05%
Average Trading Volume: 3,386
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €830.4M
See more insights into 1681 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue